February 12, 2024
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, joins healthcare and humanitarian non-profits throughout the world in calling for a medical corridor to allow immediate access to lifesaving supplies and medicines, like insulin, needed by all people living with T1D in the Middle East conflict zone. At all times, including times of conflict, people with T1D need insulin to live, regardless of race, religion, or national origin. Breakthrough T1D urges those with influence in the region to aid in preserving life by joining our organization in supporting this effort.
February 12, 2024
